217 related articles for article (PubMed ID: 33633566)
1. Severe Acute Respiratory Syndrome Coronavirus-2 Induces Cytokine Storm and Inflammation During Coronavirus Disease 19: Perspectives and Possible Therapeutic Approaches.
Mannino F; Bitto A; Irrera N
Front Pharmacol; 2020; 11():592169. PubMed ID: 33633566
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review.
Farooqi F; Dhawan N; Morgan R; Dinh J; Nedd K; Yatzkan G
Trop Med Infect Dis; 2020 Jul; 5(3):. PubMed ID: 32635353
[TBL] [Abstract][Full Text] [Related]
4. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
[TBL] [Abstract][Full Text] [Related]
5. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths.
Lai CC; Liu YH; Wang CY; Wang YH; Hsueh SC; Yen MY; Ko WC; Hsueh PR
J Microbiol Immunol Infect; 2020 Jun; 53(3):404-412. PubMed ID: 32173241
[TBL] [Abstract][Full Text] [Related]
6. Cytokine Response in SARS-CoV-2 Infection in the Elderly.
Sherwani S; Khan MWA
J Inflamm Res; 2020; 13():737-747. PubMed ID: 33116752
[TBL] [Abstract][Full Text] [Related]
7. Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19.
Kumar R; Rathi H; Haq A; Wimalawansa SJ; Sharma A
Virus Res; 2021 Jan; 292():198235. PubMed ID: 33232783
[TBL] [Abstract][Full Text] [Related]
8. Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications.
An PJ; Zhu YZ; Yang LP
Pharmacol Res; 2020 Sep; 159():104946. PubMed ID: 32450346
[TBL] [Abstract][Full Text] [Related]
9. Fighting the Host Reaction to SARS-COv-2 in Critically Ill Patients: The Possible Contribution of Off-Label Drugs.
Scala S; Pacelli R
Front Immunol; 2020; 11():1201. PubMed ID: 32574268
[TBL] [Abstract][Full Text] [Related]
10. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
11. 2019 Novel Coronavirus Outbreak: SOS Alert for Dentists.
Vidya GS; Patil S; Raj AT
J Contemp Dent Pract; 2020 Mar; 21(3):219. PubMed ID: 32434963
[TBL] [Abstract][Full Text] [Related]
12. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
13. Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019.
Nagarkatti P; Miranda K; Nagarkatti M
Front Pharmacol; 2020; 11():589438. PubMed ID: 33240092
[TBL] [Abstract][Full Text] [Related]
14. The Global Emergency of Novel Coronavirus (SARS-CoV-2): An Update of the Current Status and Forecasting.
Hozhabri H; Piceci Sparascio F; Sohrabi H; Mousavifar L; Roy R; Scribano D; De Luca A; Ambrosi C; Sarshar M
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32764417
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).
Park SE
Clin Exp Pediatr; 2020 Apr; 63(4):119-124. PubMed ID: 32252141
[TBL] [Abstract][Full Text] [Related]
16. How COVID-19 induces cytokine storm with high mortality.
Hojyo S; Uchida M; Tanaka K; Hasebe R; Tanaka Y; Murakami M; Hirano T
Inflamm Regen; 2020; 40():37. PubMed ID: 33014208
[TBL] [Abstract][Full Text] [Related]
17. A 21st Century Evil: Immunopathology and New Therapies of COVID-19.
Silva TF; Tomiotto-Pellissier F; Sanfelice RA; Gonçalves MD; da Silva Bortoleti BT; Detoni MB; Rodrigues ACJ; Carloto ACM; Concato VM; Siqueira EDS; Costa IN; Pavanelli WR; Conchon-Costa I; Miranda-Sapla MM
Front Immunol; 2020; 11():562264. PubMed ID: 33193331
[TBL] [Abstract][Full Text] [Related]
18. Potential of Immune-Related Therapy in COVID-19.
Yuan C; Li R; Liu G; Pan Y
Front Pharmacol; 2020; 11():609212. PubMed ID: 33574756
[TBL] [Abstract][Full Text] [Related]
19. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
[TBL] [Abstract][Full Text] [Related]
20. A new era for nuclear medicine.
Chatzipavlidou V
Hell J Nucl Med; 2020; 23(1):2-3. PubMed ID: 32361714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]